Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 18, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Discusses Future of Cannabis Research Program, Competitors and More with Program’s Director

LAGUNA HILLS, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
April 10, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech’s Cannabis Research Program Sees Significant Progress in University of Northern Colorado Presentations

LAGUNA HILLS, Calif., April 10, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
April 03, 2017 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Appoints Dr. Mark Rabe Director of Cannabis Program Development

LAGUNA HILLS, Calif., April 03, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
March 22, 2017 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing

LAGUNA HILLS, Calif., March 22, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
March 17, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech CEO Addresses IND Submission Questions

LAGUNA HILLS, Calif., March 17, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
March 13, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Names Dr. Leonard Makowka as Senior Strategic Advisor

LAGUNA HILLS, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
February 21, 2017 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial

LAGUNA HILLS, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
February 13, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity

LAGUNA HILLS, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
February 08, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Releases Shareholder Call and Complete Q&A Playback Information

LAGUNA HILLS, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing therapies for cancer and diabetes using...
February 02, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Provides Update for February 7th Shareholder Call

LAGUNA HILLS, Calif., Feb. 02, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing therapies for cancer and diabetes using...